Vela Technologies Investors - VELA

Vela Technologies Investors - VELA

Buy
Sell
Stock Name Stock Symbol Market Stock Type
Vela Technologies Plc VELA London Ordinary Share
  Price Change Price Change % Stock Price Last Trade
0.0005 2.5% 0.0205 13:34:07
Open Price Low Price High Price Close Price Previous Close
0.02 0.02 0.0205 0.0205 0.02
more quote information »
Industry Sector
MEDIA

Top Investor Posts

Top Posts
Posted at 01/2/2022 10:30 by mwgunshow
From the LSE chat. This is why small PI get burned as they lose hope and listen to nuggets like Pwhite on chat boards.


@RiseOfThePorper, What an amazing find, this is BIG news. Recommend everyone read the corporate presentations (under corporate profile)

AZD1656 has been developed to treat diabetics hospitalised due to Covid-19 to reduce mortality.
- Conduit raised £10.3m through an SPV with Excalibur Medicines Limited including a £3m grant from UKRI.
- Following completion of a successful trial, an exit to a third party is under negotiation, Conduit retain 22% of all economic benefit.
- Conduit raised a further £2.35m through a partial asset sale to Vela Technologies PLC, a UK listed Investment Company

SGS is an investor in Conduit Pharma (based in Cayman Islands) & the best bit:-
$716m NPV to EML and Conduit assuming conditional marketing authorization obtained Year 1 (page 12)

How much to Vela?
It's going to happen!!

Posted at 16/9/2021 21:31 by capitalgains5
This could drop tomorrow after 9am. People ramping on the fact sgs shares have been sold to other investors then who the hell has been selling causing this drop. If sgs shares have been sold below current price then it is an easy flip for investors. I predict initial rise tomorrow followed by a drop. Mms hold a lot of shares imo GLA holders .. hopefully it bags and your not left holding bags
Posted at 15/9/2021 12:35 by pwhite73
Tom - You've modified your original comment. However it was exactly what I am saying. Your and my analogy applies to any therapeutic drug at trial stage targeted for a specific illness. Considering tens of millions have been effected with Covid the question that applies to all therapeutic trial drugs is what are its effects on patients who have been affected with Covid-19 can it help?

Vela has created a diversionary route to entice new investors in a process that is a natural progression for any therapeutic drug at the moment. This diversionary tactic has cost investors a lot of money. The whole ARCADIA trial is an utter nonsense all therapeutic drug companies are doing Arcadia type trials during this pandemic as a matter of course because they have no choice Covid is everywhere and especially in hospitals. I hope this makes things clearer.

Once again AZD1656 is a diabetes drug not a Covid drug. If it can cure the effects of diabetes then by default it will mitigate against the effects of Covid.

Posted at 08/9/2021 16:05 by pwhite73
You all have every right to get excited because red is all AIM/smallcap investors ever know. Once it hits the leader board people move money from their red stocks to Vela that is blue ahead of results on Friday. Some on LSE are comparing the meteoric rise of SNG to Vela not aware that Vela are not a pharma company but a loss making investment company that has jumped on the Covid pharma bandwagon as it did crypto and every other fad. Sells outstrip buys but the price is up that's because the MM want to keep upward momentum into Friday whilst blocking PIs who try to exit in any decent amounts.

It is right and proper that investors feel good about themselves because this is an extremely rare occasion. However shortly it will be business as usual with Vela and I would not even rule out another equity issue before Friday.

Posted at 08/9/2021 12:07 by pwhite73
blueblood - "What about the upfront licensing fees say £200m+"

SGS is a registered charity. Any money they make must be to fund the charity not to pay out huge profits to investors. Investors receive back their original investment and a small amount on top that they would have otherwise gained in a high yield interest rate bank account that's all. There may well have been tax advantages for Vela investing in SGS.

RNS 20/10/2020 - "St George Street is a UK-based medical-charity led by a group of highly decorated academics and ex-pharma executives formed to deliver much needed treatments to patients. SGS's strategy is to take clinical-ready assets from pharmaceutical companies and to progress them through Phase II medical trials, before licensing them on for Phase III trials and commercialisation in order to create a return for investors and the charity alike."

Posted at 12/8/2021 17:09 by bapodra_investments
Blueblood - Vela has issued a lot of shares. It is in the billions rather than millions. That is a fact. So why is this a problem? Every time Vela has issued additional shares, it has increased the number of shares being traded in the market. Now for existing shareholders like me who have been invested since 2017 (this is not my finest moment as an investor) the excessive shares have led to the dilution of the shares. This is because the additional shares that Vela have issued will have reduced the value of the existing shares that investors like myself and others held.

So for new investors or even newer investors it may not present the same issue as an investor who has seen Vela issue shares galore over the past four years. Where as an investor who has just invested and has not experienced share dilution will have a different experience. This is why I invested at I think it was 0.08p a few months back to mitigate the share dilution I had suffered and bring my average significantly down in the process.

Now if Vela were issuing those extra shares which led to capital being invested which increased the valuation of the company, shareholders could see a benefit. However, if Vela chose to service debt and working capital then it could have the opposite impact for existing shareholders.

So as an investor if you held 1% of the shares and Vela issue more shares, you now hold less than 1% of Vela's shares unless you bought more to maintain your percentage of holding. The key for me personally is if Vela is using the issuing of shares to boost revenues or significantly increase the valuation of its investments. Unfortunately since I have been an investor in Vela I have not experienced this hence why the excessive shares is an issue for some of us but not for others.

Posted at 10/8/2021 17:50 by bapodra_investments
blueblood - I understand your point about market cap and it is a valid one. However when you have billions of shares and a minuscule share price, it can detract certain investors who choose not to invest. It is that perception and unless all investors think like you, which many will not, they will stay away from Vela in its current state.

I don't disagree with your point but unfortunately there will be many investors who will not invest in Vela. Whether that is right or wrong is a different point but lets see what happens to the share price once the SGS Capital results are known. Does the share price go up if positive results and stay up or does it come straight back down? Because there are so many shares available, traders, only need a very small movement in price and can profit. They can then 'rinse and repeat' this to death.

Posted at 22/7/2021 11:54 by bapodra_investments
PWhite73 - If you go back many months when Vela invested in SGS Capital, I was one of the first to challenge the wisdom of this as I could not see how it fitted into the 'disruptive technology' area. I was of course told I did not understand and the belittlers came out in their droves. I am not someone who works in the medical profession so I am not an expert in this area. I did not invest in Vela for exposure to this area yet here we are awaiting these results. I do not know if they will be positive or not. Even positive results do not necessarily mean money coming into Vela's bank account anytime soon.

If SGS Capital does not lead to Vela's share price rising then it will deter any investors adding to their position or new investors. Vela's largest investment under James Normand is in SGS Capital so it really need to bring value to Vela shareholders or we could see a lot of smaller investors exiting.

I of course want the trial results to be positive and for a large commercialisation deal to be secured which benefits the shareholders of Vela in terms of increase in valuation.

Posted at 24/4/2021 12:20 by bapodra_investments
bullrun1 - I agree about consolidation and I would be surprised if James Normand and the team are not thinking about that. I think they may want to dispose of any non performing legacy investments first and make any further new investments before doing so. That is just my personal view.

blue blood - I think most investors agree it would make sense to attract newer investors. The share price is making Vela look like a high risk penny share which may put a lot of investors off. Of course it is high risk and yes it is a penny share but in my view Vela is more like a technology fund investing in listed and unlisted companies and is very similar to a VCT - Private Equity vehicle but it may not give that perception at first glance to new potential investors.

Posted at 27/1/2021 12:44 by bapodra_investments
Rebel - Exactly - your last sentence is what I agree on. Investors need to look at Vela from a risk/reward perspective. Some will not have the stomach for it and others like us will. We may have a higher risk tolerance than other investors. Just because we both have invested in Vela does not mean it is going to succeed. I accept that I could be wrong and Vela may not provide me with a profit but it is a risk I am prepared to take based on the potential reward available.

Your second paragraph - I am talking about investing in Vela from a share price perspective. I am not saying Vela Technologies itself is a high risk. I am suggesting that investing in the company is high risk based on share price performance. Those investors who invested a few years ago have seen their capital diminished and it is this probability or more likelihood of making a loss which is what makes investing in Vela high risk, not the company itself is high risk.

Anyway - It is good that we are both on the same side as investors who have invested in Vela and are shareholders in this company. We want this company to succeed which goes without saying. I agree with you that we need to give JN at least 12 months to see what he can demonstrate. I actually think 2021 should be a positive year for Vela if it can make some new investments and its existing investments do well such as Mode.

Your Recent History
LSE
VELA
Vela Techn..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221203 18:49:51